- Post acute myocardial infarction (AMI) care, involving therapeutic and rehabilitative strategies following a heart attack, is becoming an essential component of cardiovascular healthcare systems worldwide due to its role in reducing recurrence, improving survival rates, and enhancing quality of life among patients
- The increasing demand for post-AMI interventions is primarily fueled by the rising global incidence of myocardial infarctions, expanding aging populations, and growing awareness of the importance of structured post-MI care—including pharmacological therapy, cardiac rehabilitation, and lifestyle modifications
- North America dominated the post acute myocardial infarction market with the largest revenue share of 42% in 2024, attributed to high healthcare expenditure, robust reimbursement frameworks, widespread access to advanced therapies, and the presence of key pharmaceutical and medical device players
- Asia-Pacific is expected to be the fastest growing region in the post acute myocardial infarction market during the forecast period, due to increasing cardiovascular disease burden, improving healthcare infrastructure, and greater governmental focus on non-communicable disease management
- The beta-blockers segment dominated the post acute myocardial infarction therapeutics market with a market share of 37.2% in 2024, driven by its long-standing clinical efficacy in reducing mortality and preventing reinfarction post-event
